The formation of functionally distinct muscles, including the myocardium, requires the orderly expression, assembly, and interaction of a large number of proteins, many of which are members of multigene families encoding closely related but distinct isoforms. This is underscored by diseases such as familial hypertrophic cardiomyopathy which can result from mutations in at least three different muscle proteins representing both thick and thin filaments: myosin heavy chain, troponin C, or tropomyosin. This proposal focuses on the physiological significance of cardiac actin which forms the backbone of the thin filaments in the cardiomyocytes. The actin gene family includes four closely related proteins (cardiac-, skeletal-, vascular- and enteric-actin) which constitute the predominant actin in the muscles for which they are named. The principal hypotheses to be tested are that (1) the predominance of cardiac actin in the normal adult mouse heart is due to a unique physiological requirement(s) for this isoform; and (2) the structural differences among the muscle actins are related to unique functional properties of the individual members of this gene family. The applicant plans to test these hypotheses by replacing cardiac actin in the mouse heart with enteric, skeletal, or vascular actin and determining the structural or functional effects, if any, in the myocardium. If there are any effects, the applicant will initiate an analysis of the contribution of selected amino acid exchanges among the muscle actins to the observed structural, molecular, and physiological changes in the myocardium. The applicant will exploit a transgenic mouse model he has generated by ablating the cardiac actin gene in embryonic stem (ES) cells. Animals lacking cardiac actin form a functioning four-chambered heart but die within a few days of birth. The applicant has now """"""""rescued"""""""" this lethal phenotype by ectopically expressing enteric actin in the heart using the cardiac a-myosin heavy chain (aMHC) promoter and preliminary results indicate that the hearts are enlarged and hypodynamic. The applicant proposes to alter the exons of the cardiac actin gene using double replacement or """"""""knock-in"""""""" strategies to encode and, thus, appropriately express the alternative muscle actin in place of cardiac actin. As functional differences are revealed in the whole animal, isolated heart, or purified myofibrils, the importance of selected amino acid differences will be assessed by producing chimeric actins in the heart.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL057291-05
Application #
6343563
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Reinlib, Leslie
Project Start
1997-01-01
Project End
2002-12-31
Budget Start
2001-01-01
Budget End
2002-12-31
Support Year
5
Fiscal Year
2001
Total Cost
$341,813
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Abdelwahid, Eltyeb; Pelliniemi, Lauri J; Szucsik, John C et al. (2004) Cellular disorganization and extensive apoptosis in the developing heart of mice that lack cardiac muscle alpha-actin: apparent cause of perinatal death. Pediatr Res 55:197-204
Kumar, A; Crawford, K; Flick, R et al. (2004) Transgenic overexpression of cardiac actin in the mouse heart suggests coregulation of cardiac, skeletal and vascular actin expression. Transgenic Res 13:531-40
Hofmann, Wilma A; Stojiljkovic, Ljuba; Fuchsova, Beata et al. (2004) Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II. Nat Cell Biol 6:1094-101
Martin, Anne F; Phillips, Ronald M; Kumar, Ajit et al. (2002) Ca(2+) activation and tension cost in myofilaments from mouse hearts ectopically expressing enteric gamma-actin. Am J Physiol Heart Circ Physiol 283:H642-9